"paper"

In this paper, the authors describe a case of facial nerve palsy as a neurological manifestation of Covid-19 Infection.

In this nice paper, recently published in the European Journal of Neurology, the authors reviewed neurological manifestations in patients with COVID-19 and the possible neuro-invasive mechanisms of Sars-CoV-2.

In this paper, the authors report three patients infected with SARS-CoV-2 who developed generalised myoclonus. Two men and one woman (aged 63 to 88) presented with mild hypersomnia and generalised myoclonus following onset of the so-called “inflammatory” phase of COVID-19 infection.

The European Academy of Neurology has installed three series of named lectures. They are named after three outstanding European neurologists and are reserved for outstanding active basic and clinical scientists. The awardees are selected by the EAN.

The Opening Session of the sixth EAN Congress, the first Virtual EAN Congress in our society's history, was special in more than one way. The unprecedented upheaval of the global COVID-19 pandemic affects societies across the globe and mirrors the turbulent times we all live in. EAN has made a great contribution to improve this unsettling situation by moving the 6th EAN Congress online and offering free registration to all, providing thousands of medical professionals with important access to medical education.

COVID-19 has swept across Europe and the world since the turn of the year, and resulted in this highly topical session being added to the virtual Congress programme 2020, as a further response to the pandemic. Reflecting the common challenges we all face, and the importance of international cooperation, this was a joint EAN/AAN session, chaired by Professor Claudio Bassetti and Professor James Stevens, the Presidents of our two Associations.

In this paper, Dinkin et al., describe two patients who developed cranial neuropathies within days of respiratory symptoms related to SARS-CoV-2 infection and were found to have abnormal perineural or cranial nerve findings on MRI.

In this paper, the authors report the case of a 40-year-old man who developed acute brainstem dysfunction 3 days after hospital admission with symptoms of COVID-19 infection.

This paper, recently published in Revue Neurologique, summarises recommendations for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network (FILNEMUS).

Most medical centres are postponing elective procedures and deferring non-urgent clinic visits to conserve hospital resources and prevent spread of COVID-19.

In this paper, the authors report a patient treated with natalizumab for relapsing-remitting MS who developed COVID-19 and recovered in a few days without complications.

In this paper published in Neurology, the authors conducted a scoping review of available literature on COVID-19 to assess the potential impact on neurologists in terms of prevalent comorbidities and incidence of new neurological events in patients hospitalized with COVID-19.

n this paper recently published in JAMA, the authors evaluated the prevalence, intensity, and timing of an altered sense of smell or taste in mildly symptomatic patients with SARS-CoV-2 infection.

In this paper recently published in Movement Disorders, Prasad et al., surveyed the perceptions of 100 patients with Parkinson’s disease (PD) and their caregivers who were under follow-up at the National Institute of Mental Health and Neurosciences, Bengaluru, India on the implications of Covid-19 infection.